Xuan Gu Bao·2025-05-30 02:40Group 1: Market Performance - The brain science sector showed strong performance on May 30, with companies like Innovation Medical and Aipeng Medical seeing significant stock price increases, with Aipeng Medical rising over 15% during trading [1][2]. Group 2: Neuralink Developments - Neuralink, Elon Musk's brain-machine interface company, completed a $600 million financing round, with a pre-financing valuation of $9 billion [3]. - Neuralink's device, Link, received "breakthrough device" designation from the FDA, aimed at helping patients with severe speech disabilities [3]. - The National Healthcare Security Administration released guidelines for pricing new neuro-system medical services, including specific pricing for invasive and non-invasive brain-machine interfaces [3]. Group 3: Institutional Insights - Brain-machine interfaces are expected to become a core technology for human-machine interaction, initially focusing on medical rehabilitation, with future applications in education, entertainment, military, and industrial sectors [4]. - The FDA's certification of Neuralink indicates a positive outlook for the clinical application of brain-machine interface devices, potentially accelerating commercialization [4]. - The establishment of a specialized pricing standard for brain-machine interface technology by the National Healthcare Security Administration addresses the challenge of rapid development versus slow implementation, creating a policy framework for pricing and quality control [4].